Jiankai Zhong

807 total citations · 1 hit paper
19 papers, 584 citations indexed

About

Jiankai Zhong is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Jiankai Zhong has authored 19 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Jiankai Zhong's work include Mitochondrial Function and Pathology (6 papers), Adipose Tissue and Metabolism (4 papers) and Genetics, Aging, and Longevity in Model Organisms (2 papers). Jiankai Zhong is often cited by papers focused on Mitochondrial Function and Pathology (6 papers), Adipose Tissue and Metabolism (4 papers) and Genetics, Aging, and Longevity in Model Organisms (2 papers). Jiankai Zhong collaborates with scholars based in China and United States. Jiankai Zhong's co-authors include Ying Tan, Jianhua Lu, Maolong Dong, Xiaochan Xiao, Jing He, Chen Cai, Yaoyuan Zhang, Feng Wu, Sainan Chen and Sulin Zheng and has published in prestigious journals such as Journal of Cellular Physiology, Metabolism and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Jiankai Zhong

18 papers receiving 577 citations

Hit Papers

Mitochondrial quality control mechanisms as molecular tar... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiankai Zhong China 13 321 159 100 83 58 19 584
Manling Liu China 17 388 1.2× 110 0.7× 128 1.3× 102 1.2× 74 1.3× 30 823
Jun Song China 14 406 1.3× 112 0.7× 142 1.4× 57 0.7× 134 2.3× 31 832
Wen‐Wu Bai China 14 254 0.8× 144 0.9× 61 0.6× 158 1.9× 59 1.0× 23 570
Quan Pan United States 15 342 1.1× 115 0.7× 141 1.4× 46 0.6× 99 1.7× 34 664
Naoichi Sato Japan 7 203 0.6× 142 0.9× 198 2.0× 86 1.0× 53 0.9× 11 625
Miroslava Šimáková Czechia 15 320 1.0× 119 0.7× 230 2.3× 104 1.3× 83 1.4× 50 721
Aslı F. Ceylan Türkiye 13 228 0.7× 139 0.9× 90 0.9× 136 1.6× 39 0.7× 29 588
Weijing Liu China 14 279 0.9× 170 1.1× 127 1.3× 118 1.4× 61 1.1× 41 703
Volkan Sözer Türkiye 14 165 0.5× 107 0.7× 145 1.4× 75 0.9× 72 1.2× 35 540
William H. Boylston United States 11 428 1.3× 149 0.9× 195 1.9× 101 1.2× 68 1.2× 11 767

Countries citing papers authored by Jiankai Zhong

Since Specialization
Citations

This map shows the geographic impact of Jiankai Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiankai Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiankai Zhong more than expected).

Fields of papers citing papers by Jiankai Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiankai Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiankai Zhong. The network helps show where Jiankai Zhong may publish in the future.

Co-authorship network of co-authors of Jiankai Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Jiankai Zhong. A scholar is included among the top collaborators of Jiankai Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiankai Zhong. Jiankai Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Qin, Tao, et al.. (2024). Matrix Metalloproteinase and Aortic Aneurysm: A Two-sample Mendelian Randomization Study. Annals of Vascular Surgery. 105. 227–235. 3 indexed citations
2.
Li, Shuhuan, et al.. (2024). Prognostic value of red blood cell distribution width-to-albumin ratio in ICU patients with coronary heart disease and diabetes mellitus. Frontiers in Endocrinology. 15. 1359345–1359345. 12 indexed citations
3.
Li, Shuhuan, et al.. (2024). Serum Irisin Levels are Inversely Correlated with Acute Ischaemic Stroke Incidence: Implications for Early Diagnosis in Southern China. International Journal of General Medicine. Volume 17. 5273–5284.
4.
Li, Shuhuan, et al.. (2023). The lactate to albumin ratio linked to all-cause mortality in critically ill patients with septic myocardial injury. Frontiers in Cardiovascular Medicine. 10. 1233147–1233147. 8 indexed citations
5.
Li, Shuhuan, et al.. (2023). Role of RIPK3‑CaMKII‑mPTP signaling pathway‑mediated necroptosis in cardiovascular diseases (Review). International Journal of Molecular Medicine. 52(4). 31 indexed citations
6.
Cai, Chen, Feng Wu, Jing He, et al.. (2022). Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies. International Journal of Biological Sciences. 18(14). 5276–5290. 43 indexed citations
7.
Chang, Xing, Yukun Li, Chen Cai, et al.. (2022). Mitochondrial quality control mechanisms as molecular targets in diabetic heart. Metabolism. 137. 155313–155313. 122 indexed citations breakdown →
8.
Zhong, Jiankai, et al.. (2021). Melatonin Attenuates ox‐LDL‐Induced Endothelial Dysfunction by Reducing ER Stress and Inhibiting JNK/Mff Signaling. Oxidative Medicine and Cellular Longevity. 2021(1). 5589612–5589612. 24 indexed citations
9.
Li, Rui, et al.. (2020). Ixazomib-associated cardiovascular adverse events in multiple myeloma: a systematic review and meta-analysis. Drug and Chemical Toxicology. 45(4). 1443–1448. 8 indexed citations
10.
Li, Qian, et al.. (2020). Combination of melatonin and irisin ameliorates lipopolysaccharide‐induced cardiac dysfunction through suppressing the Mst1–JNK pathways. Journal of Cellular Physiology. 235(10). 6647–6659. 43 indexed citations
11.
Zhong, Jiankai, et al.. (2020). The YAP/SERCA2a signaling pathway protects cardiomyocytes against reperfusion-induced apoptosis. Aging. 12(13). 13618–13632. 15 indexed citations
12.
Tan, Ying, Sainan Chen, Jiankai Zhong, Jun Ren, & Maolong Dong. (2019). Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy. Current Pharmaceutical Design. 25(18). 2060–2070. 41 indexed citations
13.
Zhong, Jiankai, et al.. (2019). Inhibitory effect of melatonin on Mst1 ameliorates myocarditis through attenuating ER stress and mitochondrial dysfunction. Journal of Molecular Histology. 50(5). 405–415. 23 indexed citations
14.
Tan, Ying, et al.. (2019). Irisin ameliorates septic cardiomyopathy via inhibiting DRP1-related mitochondrial fission and normalizing the JNK-LATS2 signaling pathway. Cell Stress and Chaperones. 24(3). 595–608. 57 indexed citations
15.
Zhong, Jiankai, et al.. (2019). Tanshinone IIA attenuates cardiac microvascular ischemia-reperfusion injury via regulating the SIRT1-PGC1α-mitochondrial apoptosis pathway. Cell Stress and Chaperones. 24(5). 991–1003. 43 indexed citations
17.
Tu, Yan, et al.. (2015). ST-elevation myocardial infarction following systemic inflammatory response syndrome: case report. Cardiovascular journal of South Africa. 26(3). e1–e3. 3 indexed citations
18.
Li, Chen, et al.. (2015). Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits. International Journal of Molecular Medicine. 35(3). 715–723. 14 indexed citations
19.
Zhong, Jiankai, et al.. (2011). Probucol alleviates atherosclerosis and improves high density lipoprotein function. Lipids in Health and Disease. 10(1). 210–210. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026